Semalytix GmbH is based in Bielefeld, Germany, and provides an Agentic AI platform for the pharmaceutical industry. The PatientGPT-powered Atlas platform enables pharmaceutical teams to access the global ‘patient voice’ in a compliant manner and increasingly build, deploy and manage a library of proprietary, custom AI models. This ‘Agent-as-a-Service’ model makes it possible to embed patient intelligence directly into workflows, a crucial capability given that an estimated 75–85% of pharmaceutical workflows contain tasks that can be automated or supported by AI agents. In addition, this model helps companies build lasting intellectual property. This shifts the focus from temporary research to the creation of sustainable, strategic assets.